| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 916 | 5.210 | 20.395 | 15.860 | 11.611 | 14.461 | 17.392 | 17.537 | 24.848 | 20.523 |
| Total Income - EUR | 916 | 5.210 | 20.398 | 15.866 | 11.613 | 14.816 | 17.394 | 17.541 | 24.852 | 20.529 |
| Total Expenses - EUR | 591 | 2.020 | 4.126 | 8.055 | 6.506 | 6.216 | 7.354 | 8.943 | 14.913 | 10.925 |
| Gross Profit/Loss - EUR | 324 | 3.190 | 16.271 | 7.811 | 5.107 | 8.600 | 10.039 | 8.598 | 9.940 | 9.604 |
| Net Profit/Loss - EUR | 297 | 3.034 | 15.659 | 7.388 | 4.759 | 8.197 | 9.580 | 8.083 | 7.812 | 7.326 |
| Employees | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Albamed Plus Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.635 | 2.563 | 2.499 | 12.477 | 10.129 | 7.869 | 5.673 | 3.663 | 2.304 | 2.849 |
| Current Assets | 70 | 3.482 | 15.838 | 7.610 | 9.407 | 8.926 | 13.894 | 15.507 | 19.487 | 22.188 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 265 | 1.987 | 698 | 1.022 | 900 | 1.081 | 1.258 | 2.800 | 408 |
| Cash | 70 | 3.217 | 13.851 | 6.913 | 8.385 | 8.025 | 12.813 | 14.248 | 16.687 | 21.780 |
| Shareholders Funds | 342 | 3.372 | 15.992 | 7.715 | 10.361 | 13.693 | 17.224 | 12.553 | 20.327 | 15.084 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.363 | 2.674 | 2.345 | 12.373 | 9.175 | 3.102 | 2.343 | 6.617 | 1.464 | 9.954 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Albamed Plus Srl